CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer (Q50607666)
Jump to navigation
Jump to search
scientific article published on 19 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer |
scientific article published on 19 July 2016 |
Statements
CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer (English)
1 reference
Xiaofei Zhang
1 reference
Hideki Shimodaira
1 reference
Hiroshi Soeda
1 reference
Keigo Komine
1 reference
Hidekazu Takahashi
1 reference
Kota Ouchi
1 reference
Masahiro Inoue
1 reference
Masanobu Takahashi
1 reference
Shin Takahashi
1 reference
Chikashi Ishioka
1 reference
19 July 2016
1 reference
21
1 reference
6
1 reference
1091-1101
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference